A big thanks to @LaurenXandra_ and the @TwoSigmaVC team for this great profile of our CEO and co-founder @MHillenmeyer discussing our novel approach of mining microbial #genomes to discover new medicines for patients!
#ArtificialIntelligence #MachineLearning #Genomics
#ArtificialIntelligence #MachineLearning #Genomics
On the heels of @hexagonbio's $77.3M Series B, we share the story of Founder and CEO Maureen Hillenmeyer’s ambition to identify medicines in the global metagenome and bring them to patients.View quoted post on X
twosigmaventures.com/blog/article/s…